Kiren Gill

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 131 citations · Full text

Difference Between Latiglutenase, Villous Atrophy, Clinical Presentation +3

Reassessment of Routine Midstream Culture in Diagnosis of Urinary Tract Infection

Sanchutha Sathiananthamoorthy, James Malone‐Lee, Kiren Gill et al. · Journal of Clinical Microbiology · 2018 · 61 citations · Full text

Use of stents for treating obstruction of urinary outflow in patients unfit for surgery.

G. Williams, J. Brian McLoughlin, A. EL DIN et al. · BMJ · 1989 · 60 citations · Full text

Urinary Outflow, Urology, Voiding Dysfunction +5

Symptoms versus Flow Rates versus Urodynamics in the Selection of Patients for Prostatectomy

J. Brian McLoughlin, Kiren Gill, P D Abel et al. · British Journal of Urology · 1990 · 58 citations

Urology, Cystometric Evidence, Pelvic Prolapse +8

Urinary ATP as an indicator of infection and inflammation of the urinary tract in patients with lower urinary tract symptoms

Kiren Gill, Harry Horsley, Anthony Kupelian et al. · BMC Urology · 2015 · 33 citations · Full text